The Victorian Government has announced that women will be able to obtain the contraceptive pill directly from pharmacies without first seeing a GP.
This is the latest expansion of the Community Pharmacist Program, now styled “Chemist Care Now”. Each change is presented as a small improvement in convenience. Taken together, they steadily move prescribing decisions away from clinical care.
This is one of the most concerning examples yet.
The Government says the change will “save women time” and give women “more options to get the care they need”. Access to contraception matters, and women should be able to obtain safe and appropriate care without unnecessary barriers. Doctors support women having timely access to contraception and the ability to choose the option that is right for them. But prescribing medication is not simply a convenience service.
Hormonal contraceptive pills are prescription medicines in Australia for a reason. Prescribing them normally involves taking a medical history, reviewing medications and risk factors, and identifying issues that may affect safety or suitability for that individual woman. It also provides an opportunity to address other aspects of a patient’s health.
The Government’s announcement states that pharmacists will provide advice about other contraceptive options, including long-acting reversible contraception. Those conversations matter. And they belong in a clinical consultation where the practitioner has access to the patient’s medical history and can provide or arrange appropriate care. Pharmacists participating in the program will complete a short training module. That is not equivalent to the clinical training required to assess contraception, identify risk factors, and manage complications. Pharmacies are not designed to provide the same level of comprehensive clinical assessment that occurs in a medical consultation.
Women can already obtain up to a 12 month prescription for the contraceptive pill from their GP. The consultation that provides that prescription also allows time for a broader women’s health discussion. It may include sexual health advice, reminders about STI testing, and consideration of other contraceptive options. These elements of care are difficult to replicate in a brief pharmacy encounter.
Women also benefit from continuity of care. Pharmacy consultations occur outside the patient’s usual medical record and with limited clinical information. Information may be uploaded to My Health Record, but there is no assurance the patient’s GP will even know the consultation occurred.
The program also raises a conflict that has been pointed out repeatedly. The practitioner assessing the patient is also supplying the medicine in the same transaction. Prescribing and dispensing have traditionally been separated for good reason. If convenience now outweighs that principle, it is reasonable to ask whether doctors will also be permitted to dispense the medicines they prescribe.
There is also a practical consequence. When complications arise or treatment needs to change, patients often return to general practice. GPs are then left to manage the consequences of prescribing decisions they did not make.
This is being presented as a simple access reform. It is not. It removes another prescribing decision from clinical care.
If the Government wants to improve access to contraception, it should strengthen access to general practice so women can receive timely, safe and comprehensive care rather than bypassing it.
AMA Victoria will continue to advocate for safe, coordinated care led by doctors.